Skip to main content

Table 4 HPLC Analysis of Artemisinin derivative (AD) of ACT

From: Quality of Artemisinin-based Combination Therapy for malaria found in Ghanaian markets and public health implications of their use

Artemisinin Derivative

Below 85 %

Within 85–115 %

Above 115 %

Total

n (%)

n (%)

n (%)

N = 254

Artesunatea

n (%)

25 (22.5)

86 (77.5)

0 (0.0)

111 (100.0)

Median (IQR)

80.0 (77.2–82.7)

92.9 (89.5–98.6)

0

91.5 (86.0–95.8)

Artemetherb

n (%)

6 (4.5)

126 (94.0)

2 (1.5)

134 (100.0)

Median (IQR)

76.6 (66.8–77.5)

95.9 (92.1–100.4)

116.1 (115.1–117.0)

95.6 (91.5–100.5)

Dihydroartemisinc

n (%)

0 (0.0)

6 (66.7)

3 (33.3)

9 (100.0)

Median (IQR)

0

105.1 (89.2–107.3)

132.4 (120.3–143.2)

107.3 (103.4–120.3)

Combined

n (%)

31 (12.2)

218 (85.0)

5 (2.0)

254 (100.0)

Median (IQR)

78.7 (76.7–82.5)

94.6 (90.9–99.9)

120.3 (117.0–132.4)

93.6 (89.4–99.7)

  1. Note: a, b, cwere derived from Artesunate Amodiaquine. Artemether Lumefantrine and Dihydroartemisinin Piperaquine respectively